N. Fournier

Discipline

Psychology (3) Linguistics (1) History, Philosophy and Sociology of Sciences (1)

Type

Articles (25) Conferences and symposiums (6) Reviews (1)

Co-author

Date

Source

Keyword

Patients (21) Patients (21) cohort (17) Swiss (15) disease (11) Treatment (11) Inflammatory bowel diseases (11) Risk factors (11) disease (11) Human beings (10) Ulcerative colitis (9) therapy (8) Therapeutics (8) Crohn's disease (8) Older people (8) risk (7) adult (7) Methods (7) Risk (7) Manufacturers' agents (7) Commission merchants (7) Methods (7) adult (7) well (6) age (6) Surgery (6) Inhibitors (6) Surgery (6) Age (6) Age (6)

Documents written by N. Fournier (26) | is about N. Fournier (0)

The local microenvironment drives activation of neutrophils in human brain tumors.
R.R. Maas et al. (Oct 12, 2023)
Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation.
V. Wischnewski et al.
Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophages.
M. Tichet et al. (Jan 10, 2023)
Multispectral fluorine-19 MRI enables longitudinal and noninvasive monitoring of tumor-associated macrophages.
D. Croci et al. (Oct 19, 2022)
Apelin-driven endothelial cell migration sustains intestinal progenitor cells and tumor growth.
J. Bernier-Latmani et al.
Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL.
M. Antoszewski et al. (Apr 21, 2022)
The Influence of Breastfeeding, Cesarean Section, Pet Animals, and Urbanization on the Development of Inflammatory Bowel Disease: Data from the Swiss IBD Cohort Study.
S.A. Lautenschlager et al.
Effect of Pre-Hospital Intubation in Patients with Severe Traumatic Brain Injury on Outcome: A Prospective Cohort Study.
C. Choffat et al. (Apr 6, 2019)
Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.
L. Biedermann et al. (2019)
The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort.
A. Hiller et al. (2019)
Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.
N. Roth et al. (2019)
Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study.
L. Bon et al. (2019)
Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort.
S. Godat et al.
The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients.
B. Yilmaz et al. (2018)
Pain perception after colorectal surgery: A propensity score matched prospective cohort study.
F. Grass et al. (2018)
P719 Determinants of tobacco consumption in the Swiss IBD cohort
M. Grueber et al. (Feb 1, 2017)
Efficacy of an adjunctive brief psychodynamic psychotherapy to usual inpatient treatment of depression: Results of a randomized controlled trial.
Y. de Roten et al.
Is standardized care feasible in the emergency setting? A case matched analysis of patients undergoing laparoscopic cholecystectomy.
F. Grass et al. (Dec 1, 2016)
Contribution à l’étude de la quantification de la durée entre le XVIe s. et le XXe s.
N. Fournier et al. (Mar 7, 2016)
Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account.
J. Zeitz et al. (2016)
Prevalence and risk factors for therapy escalation in ulcerative colitis in the Swiss IBD Cohort Study
E. Safroneeva et al. (2015)
Azathioprine and 6-Mercaptopurine use in the Swiss IBD cohort : adverse effects, causes of discontinuation and risk of "flares" according to 6-TG levels
D. Lavrek et al. (2015)
Systematic evaluation of clinical predictors of aggressive ulcerative colitis
S. Vavricka et al. (2015)
Prospective pathways between heroin use and nonmedical use of prescription opioids: Trajectories among young Swiss men
S. Baggio et al. (2015)
Prevalence and risk factors for thromboembolic complications in IBD patients
A. Schoepfer et al. (2015)

next